Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Abbott Laboratories

Market Cap 154B 134B 124B 116B 218B 14,531B 220B 1,475B 572B 7,152B 578B 566B 24,834B P/E 2026 *
22.2x
P/E 2027 * 19.1x
Enterprise Value 166B 144B 134B 125B 235B 15,637B 236B 1,588B 615B 7,697B 622B 609B 26,725B EV / Sales 2026 *
3.3x
EV / Sales 2027 * 2.97x
Free-Float
86.73%
Yield 2026 *
2.88%
Yield 2027 * 3.07%
1 day-0.39%
1 week+1.80%
Current month+4.51%
1 month+0.47%
3 months-18.47%
6 months-28.12%
Current year-27.11%
1 week 75.16
Extreme 75.16
78.38
1 month 73.56
Extreme 73.56
80.32
Current year 69.76
Extreme 69.76
109.34
1 year 69.76
Extreme 69.76
118.58
3 years 69.76
Extreme 69.76
133.78
5 years 69.76
Extreme 69.76
133.78
10 years 33.17
Extreme 33.166
133.78
Manager TitleAgeSince
Chief Executive Officer 52 30/03/2020
Director of Finance/CFO 53 31/08/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 08/12/2011
Director/Board Member 67 08/12/2011
Director/Board Member 71 15/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
-0.39%+1.80% - - 154B
+1.54%-1.07%-7.45%-11.00% 102B
-4.45%+3.12%+59.84%+56.09% 56.51B
-1.90%-3.49%-8.40%+48.53% 52.89B
+1.67%-1.55%-14.60%-44.33% 39.67B
-1.32%-1.83% - - 30.39B
+1.74%-3.85%-10.54%-44.30% 27.96B
+1.35%-0.26%+50.47%-9.42% 23.17B
-1.53%+1.14%-15.03%-5.42% 20.35B
+1.61%-2.38%-14.23%-5.15% 19.75B
Average -0.17%-1.39%+5.01%-1.87% 41.39B
Weighted average by Cap. -0.28%-1.23%+5.52%+3.47%

Financials

2026 *2027 *
Net sales 50.29B 43.85B 40.61B 38.02B 71.3B 4,745B 71.73B 482B 187B 2,336B 189B 185B 8,110B 54.79B 47.77B 44.25B 41.42B 77.68B 5,170B 78.15B 525B 203B 2,545B 206B 201B 8,836B
Net income 7.02B 6.12B 5.67B 5.31B 9.95B 662B 10.01B 67.24B 26.06B 326B 26.35B 25.78B 1,132B 8.39B 7.32B 6.78B 6.34B 11.9B 792B 11.97B 80.4B 31.16B 390B 31.5B 30.83B 1,353B
Net Debt 11.73B 10.22B 9.47B 8.86B 16.62B 1,106B 16.73B 112B 43.54B 545B 44.02B 43.07B 1,891B 8.88B 7.75B 7.17B 6.71B 12.59B 838B 12.67B 85.1B 32.98B 413B 33.34B 32.63B 1,433B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
19/06/26 76.90 -0.39% 215
18/06/26 77.20 -0.82% 165
17/06/26 77.84 +0.49% 80
16/06/26 77.46 +3.06% 360
15/06/26 75.16 -0.50% 976
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
88.41USD
Average target price
116.54USD
Spread / Average Target
+31.82%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!